Related Experiment Video
Updated: Sep 22, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Improved hypertension control at six months using an adapted WHO HEARTS-based implementation strategy at a large
Martin Muddu1, Fred C Semitala2, Isaac Kimera3
1Makerere University Joint AIDS Program (MJAP), P.O. Box 7072, Kampala, Uganda. muddu.martin@gmail.com.
Insights
Implementing a HEARTS strategy improved hypertension control in adults living with HIV in Uganda. This integrated care approach enhanced blood pressure management without compromising HIV control.
Area of Science:
- Public Health
- Cardiology
- Infectious Disease Management
Background:
- Hypertension (HTN) is a significant comorbidity among persons living with HIV (PLHIV).
- Effective HTN control strategies are crucial for PLHIV, who face increased cardiovascular risks.
- Integrating HTN management into existing HIV care platforms can improve patient outcomes.
Purpose of the Study:
- To adapt and implement the World Health Organization HEARTS strategy for HTN control in an urban Ugandan HIV clinic.
- To evaluate the six-month impact of this integrated strategy on HTN and HIV outcomes in adult PLHIV.
- To identify predictors of HTN control among PLHIV receiving integrated care.
Main Methods:
- A pre-post study design was employed from October 2019 to March 2020.
- The implementation strategy included health education, adherence support, routine screening, task shifting, evidence-based protocols, free medication, and monitoring tools.
- A cohort of 1,015 adult PLHIV with HTN was assessed at baseline and six months.
Main Results:
- Significant improvements in HTN outcomes were observed: mean systolic BP decreased from 154.3 to 132.3 mmHg, diastolic BP from 97.7 to 85.3 mmHg, and controlled HTN increased from 9.3% to 74.1% (all p < 0.001).
- The HTN care cascade showed substantial improvements in treatment initiation (13.4% to 100%), retention (16.2% to 98.5%), and monitoring (16.2% to 98.5%).
- HIV care metrics remained high (>95%), with viral suppression unchanged (98.7% to 99.2%, p = 0.712). ART duration and viral suppression predicted HTN control.
Conclusions:
- The HEARTS-based strategy successfully integrated HTN and HIV care, leading to improved HTN outcomes while maintaining HIV control in a large urban clinic.
- This approach demonstrates the feasibility of enhancing cardiovascular health management within HIV service delivery platforms.
- Further research is warranted to explore HTN/HIV integration in diverse settings and populations.
Objectives:
To adapt a World Health Organization HEARTS-based implementation strategy for hypertension (HTN) control at a large urban HIV clinic in Uganda and determine six-month HTN and HIV outcomes among a cohort of adult persons living with HIV (PLHIV).
Methods:
Our implementation strategy included six elements: health education, medication adherence, and lifestyle counseling; routine HTN screening; task shifting of HTN treatment; evidence-based HTN treatment protocol; consistent supply of HTN medicines free to patients; and inclusion of HTN-specific monitoring and evaluation tools. We conducted a pre-post study from October 2019 to March 2020 to determine the effect of this strategy on HTN and HIV outcomes at baseline and six months. Our cohort comprised adult PLHIV diagnosed with HTN who made at least one clinic visit within two months prior to study onset.
Findings:
We enrolled 1,015 hypertensive PLHIV. The mean age was 50.1 ± 9.5 years and 62.6% were female. HTN outcomes improved between baseline and six months: mean systolic BP (154.3 ± 20.0 to 132.3 ± 13.8 mmHg, p < 0.001); mean diastolic BP (97.7 ± 13.1 to 85.3 ± 9.5 mmHg, p < 0.001) and proportion of patients with controlled HTN (9.3% to 74.1%, p < 0.001). The HTN care cascade also improved: treatment initiation (13.4% to 100%), retention in care (16.2% to 98.5%), monitoring (16.2% to 98.5%), and BP control among those initiated on HTN treatment (2.2% to 75.2%). HIV cascade steps remained high (> 95% at baseline and six months) and viral suppression was unchanged (98.7% to 99.2%, p = 0.712). Taking ART for more than two years and HIV viral suppression were independent predictors of HTN control at six months.
Conclusions:
A HEARTS-based implementation strategy at a large, urban HIV center facilitates integration of HTN and HIV care and improves HTN outcomes while sustaining HIV control. Further implementation research is needed to study HTN/HIV integration in varied clinical settings among diverse populations.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Heart Failure V: Medical Management
Hypertension I: Introduction
Heart Failure VI: Adjunct Therapies
Errors occurring during blood pressure monitoring
Several factors...

